TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/23/25 09:12 | 6/13/25 | RZLT | Rezolute, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Kreher Nerissa | CA | D | P | 10 | 3.25 | 0 | 3 | 9 | 38 | D | |||||||||||||||
9/6/23 17:08 | 9/6/23 | TRDA | Entrada Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kreher Nerissa | MA | O | Chief Me | S.d | -12 | 13.48 | 0 | -1 | -2 | 40 | D | ||||||||||||||
8/4/23 16:50 | 8/2/23 | TRDA | Entrada Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kreher Nerissa | MA | O | Chief Me | M.dm | 56 | 2.10 | 0 | 27 | 999% | 27 | D | ||||||||||||||
8/4/23 16:50 | 8/2/23 | TRDA | Entrada Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kreher Nerissa | MA | O | Chief Me | S.dm | -394 | 14.76 | 0 | -27 | -50 | 27 | D | ||||||||||||||
3/3/23 16:32 | 3/2/23 | TRDA | Entrada Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kreher Nerissa | MA | O | Chief Me | S.d | -17 | 10.56 | 0 | -2 | -4 | 41 | D | ||||||||||||||
1/3/23 16:32 | 12/30/22 | TRDA | Entrada Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kreher Nerissa | MA | O | Chief Me | S | -70 | 13.45 | 0 | -5 | -25 | 16 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |